| A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms (NCT07629726) | Kyowa Kirin Co., Ltd. | 2026-08-01 |
| A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia (NCT07623616) | Kyowa Kirin Co., Ltd. | 2026-04-23 |
| Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance (NCT07132567) | Kyowa Kirin Co., Ltd. | 2025-05-02 |
| Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension (NCT06823947) | Kyowa Kirin Co., Ltd. | 2025-04-03 |
| Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study） (NCT06926491) | Kyowa Kirin Co., Ltd. | 2024-12-01 |
| A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia (NCT06525636) | Kyowa Kirin Co., Ltd. | 2024-10-09 |
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration (NCT06116890) | Kyowa Kirin Co., Ltd. | 2024-01-31 |
| A Study of KK2269 in Adult Participants With Solid Tumors (NCT06266299) | Kyowa Kirin Co., Ltd. | 2024-01-18 |
| Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema (NCT06116916) | Kyowa Kirin Co., Ltd. | 2024-01-09 |
| A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors (NCT06248411) | Kyowa Kirin Co., Ltd. | 2023-11-01 |
| Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO (NCT05357573) | Kyowa Kirin Co., Ltd. | 2022-09-07 |
| A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus (NCT05411016) | Kyowa Kirin Co., Ltd. | 2022-08-03 |
| Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH (NCT04842032) | Kyowa Kirin Co., Ltd. | 2021-11-01 |
| Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH (NCT04842019) | Kyowa Kirin Co., Ltd. | 2021-09-28 |
| Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia (NCT04870346) | Kyowa Kirin Co., Ltd. | 2021-05-10 |
| Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis (NCT04766398) | Kyowa Kirin Co., Ltd. | 2021-03-15 |
| Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis (NCT04771780) | Kyowa Kirin Co., Ltd. | 2021-03-15 |
| Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis (NCT04767581) | Kyowa Kirin Co., Ltd. | 2021-03-08 |
| Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis (NCT04766385) | Kyowa Kirin Co., Ltd. | 2021-03-03 |
| A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis (NCT04614298) | Kyowa Kirin Co., Ltd. | 2021-01-01 |
| Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL) (NCT04533581) | Kyowa Kirin Co., Ltd. | 2020-09-17 |
| A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration (NCT04594681) | Kyowa Kirin Co., Ltd. | 2020-09-16 |
| A Through QT/QTc Study of KW-6356 (NCT04342273) | Kyowa Kirin Co., Ltd. | 2020-03-31 |
| Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers (NCT04206657) | Kyowa Kirin Co., Ltd. | 2019-12-20 |
| Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia (NCT04095936) | Kyowa Kirin Co., Ltd. | 2019-12-03 |
| KW-3357 Study in Patients With Early Onset Severe Preeclampsia (NCT04182373) | Kyowa Kirin Co., Ltd. | 2019-11-19 |
| A Study of RTA 402 in Obese Adults (NCT04018339) | Kyowa Kirin Co., Ltd. | 2019-08-20 |
| A Study of KHK4827 in Subjects With Palmoplantar Pustulosis (NCT04061252) | Kyowa Kirin Co., Ltd. | 2019-08-10 |
| KRN125 for Mobilization of Hematopoietic Stem Cells (NCT03993639) | Kyowa Kirin Co., Ltd. | 2019-05-28 |
| A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis (NCT03957681) | Kyowa Kirin Co., Ltd. | 2019-05-23 |
| A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin (NCT03970798) | Kyowa Kirin Co., Ltd. | 2019-05-22 |
| Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NCT03985189) | Kyowa Kirin Co., Ltd. | 2019-04-29 |
| Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients (NCT03864445) | Kyowa Kirin Co., Ltd. | 2019-04-29 |
| Study of AMG531(Romiplostim) in Patients With Aplastic Anemia (NCT03957694) | Kyowa Kirin Co., Ltd. | 2019-04-25 |
| Dose-finding Study of KHK7791 in Hyperphosphatemia Patients (NCT03864458) | Kyowa Kirin Co., Ltd. | 2019-04-15 |
| Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia (NCT03822507) | Kyowa Kirin Co., Ltd. | 2019-04-09 |
| A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults (NCT04023903) | Kyowa Kirin Co., Ltd. | 2019-04-04 |
| A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects (NCT03830528) | Kyowa Kirin Co., Ltd. | 2019-02-26 |
| Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis (NCT03846466) | Kyowa Kirin Co., Ltd. | 2019-02-22 |
| A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD (NCT03831607) | Kyowa Kirin Co., Ltd. | 2018-12-27 |
| A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations (NCT03703570) | Kyowa Kirin Co., Ltd. | 2018-09-29 |
| A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study (NCT03550443) | Kyowa Kirin Co., Ltd. | 2018-05-30 |
| Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners (NCT03745521) | Kyowa Kirin Co., Ltd. | 2018-05-01 |
| A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia (NCT04308096) | Kyowa Kirin Co., Ltd. | 2018-01-09 |
| A Study of KHK4827 in Patients With Systemic Sclerosis (NCT04368403) | Kyowa Kirin Co., Ltd. | 2017-10-06 |
| Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer (NCT03291886) | Kyowa Kirin Co., Ltd. | 2017-09-22 |